A detailed history of Mbb Public Markets I LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mbb Public Markets I LLC holds 1,260 shares of BIIB stock, worth $184,552. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,260
Previous 10,455 87.95%
Holding current value
$184,552
Previous $2.42 Million 89.93%
% of portfolio
0.01%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $1.74 Million - $2.18 Million
-9,195 Reduced 87.95%
1,260 $244,000
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $1.99 Million - $2.47 Million
10,455 New
10,455 $2.42 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $205,396 - $258,788
-1,060 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $237,355 - $305,036
1,060 New
1,060 $254,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.